Finch Therapeutics Group, Inc. announced the appointment of Bryan Gillis to Chief Technology Officer, Alka Batycky, PhD, to Chief Development Officer, and Howard Franklin, to Senior Vice President, Late-Stage Development and Gastrointestinal (GI) Therapeutic Area Lead. Gillis most recently served as Vice President of Manufacturing and Supply at Rubius Therapeutics. Dr. Batycky most recently served as Chief Development Officer at Ohana Biosciences.

Dr. Franklin most recently served as Chief Medical Officer at Salix Pharmaceuticals.